Tesla offering free autopilot trials on Model S, Model X
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test autopilot without paying the standard $2,500 fee for the software.
According to the announcement made by Tesla, the free trials of autopilot software are now available for owners of Model S and Model X cars manufactured after September 2014. The Model S and Model X cars which have been manufactured after the mentioned date are already equipped with a radar system, as well as sensors and a front-facing camera positioned close to the rear-view mirror.
The autopilot software was rolled out by Tesla in October 2015. The software gives the Tesla cars the ability to parallel park, steer, and shift lanes on highways.
In addition, the autopilot software can also "be summoned" with nominal input from the driver, by relying on computer software and hardware. The software also comes with a warning system for side collisions and several other safety features.
The autopilot software is generally offered by Tesla only to customers who pay the $2,500 additional fee for an over-the-air download of the software. However, as a part of the free autopilot trial, Model S and Model X users who have not paid the stipulated fee for the software can now download it 'for free' and test it out for one month.
American aviation major Boeing has signaled its intent to unveil a modified version of its 737 MAX 10 aircraft at the opening of the Paris Airshow on Monday this week.
The odd dual-screen device called the YotaPhone 3 has been officially announced in the East Asian country of China for 2017 release.
After successfully launching its first X-ray space telescope, China is now preparing to launch four more space probes before 2021 as part of the ongoing efforts to develop space science.
The European Union (EU) is reportedly preparing to impose a record-high fine on tech giant Google (Alphabet) within the next few weeks, according to a WSJ report.
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
CenturyLink stock suffered major setback after Bloomberg published a report citing a former CenturyLink employee claiming that she was fired after she reported about fraud billing practices in the company.